Loading
Kerendia • Nonsteroidal mineralocorticoid receptor antagonist • Kidney function: 30–44 mL/min/1.73m² (or CrCl 30–50)
The recommended dose of Finerenone (Kerendia) at 30–44 mL/min/1.73m² (or CrCl 30–50) — with monitoring notes for kidney disease and dialysis.
10 mg once daily. Start only if potassium ≤4.8 mEq/L.
10 mg applies in the eGFR 25-59 range. Monitor potassium at 1 month and after dose changes.
Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.
Full Finerenone (Kerendia) kidney guideFinerenone (Kerendia) has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.
Interactive drug-dosing tool